Zobrazeno 1 - 4
of 4
pro vyhledávání: '"59"'
Autor:
Wonyoung Choi, Kun Young Lim, Youngjoo Lee, Geon Kook Lee, Seog-Yun Park, Ji-Youn Han, Minjoung Park
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Capmatinib, an oral MET kinase inhibitor, has demonstrated its efficacy against non–small cell lung cancer (NSCLC) with MET dysregulation. We investigated its clinical impact in advanced NSCLC with MET exon 14 skipping mutation (METex14) or
Autor:
Ji-Youn Han, Jin Soo Lee, Youngjoo Lee, Heung Tae Kim, Byung-Ho Nam, Tak Yun, Sung Ho Moon, Geon Kook Lee, Kun Young Lim, Hye Jin An
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Concurrent chemoradiotherapy (CCRT) is the standard care for stage III non-small cell lung cancer (NSCLC) patients; however, a more effective regimen is needed to improve the outcome by better controlling occult metastases. We conducted two p
Autor:
Yun Hwa Jung, Kyung Sun Ha, Sang Seol Jung, Il Young Park, Young Jin Suh, Guk Jin Lee, Ji Hyung Hong, In Sook Woo, Sarah Park, Woo Chan Park, Jae Ho Byun, Ji Chan Park, Su-Mi Chung, Jeong Soo Kim, Hye Sung Won, Donghoon Kang, Ho Jung An
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Breast cancer treatment has progressed significantly over the past 20 years. However, knowledge regarding male breast cancer (MBC) is sparse because of its rarity. This study is an investigation of the clinicopathologic features, treatments,
Autor:
Jin Seok Ahn, Youjin Kim, Se-Hoon Lee, Song Ee Park, Hansang Lee, Myung-Ju Ahn, Keunchil Park, Jang Ho Cho, Jae Myoung Noh, Hongryull Pyo, Jong-Mu Sun, Yoon-La Choi, Sung Won Lim, Joungho Han, Yong Chan Ahn
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose This study was conducted to evaluate the relationship between epidermal growth factor receptor (EGFR) mutation and clinical outcomes in patients with stage III non-squamous cell lung cancer treated with definitive concurrent chemoradiotherapy